A platform for designing HIV integrase inhibitors. Part 2: a two-metal binding model as a potential mechanism of HIV integrase inhibitors
- PMID: 17005407
- DOI: 10.1016/j.bmc.2006.08.043
A platform for designing HIV integrase inhibitors. Part 2: a two-metal binding model as a potential mechanism of HIV integrase inhibitors
Abstract
We propose a two-metal binding model as a potential mechanism of chelating inhibitors against HIV integrase (HIV IN) represented by 2-hydroxy-3-heteroaryl acrylic acids (HHAAs). Potential inhibitors would bind to two metal ions in the active site of HIV IN to prevent human DNA from undergoing the integration reaction. Correlation of the results of metal (Mg(2+) and Mn(2+)) titration studies with HIV IN inhibition for a series of active and inactive compounds provides support for the model. Results suggest Mg(2+) is an essential cofactor for chelating inhibitors.
Similar articles
-
A platform for designing HIV integrase inhibitors. Part 1: 2-hydroxy-3-heteroaryl acrylic acid derivatives as novel HIV integrase inhibitor and modeling of hydrophilic and hydrophobic pharmacophores.Bioorg Med Chem. 2006 Dec 15;14(24):8430-45. doi: 10.1016/j.bmc.2006.08.044. Epub 2006 Sep 28. Bioorg Med Chem. 2006. PMID: 17010623
-
Rational design and synthesis of novel dimeric diketoacid-containing inhibitors of HIV-1 integrase: implication for binding to two metal ions on the active site of integrase.J Med Chem. 2004 May 6;47(10):2561-73. doi: 10.1021/jm030559k. J Med Chem. 2004. PMID: 15115398
-
Diketo acid inhibitor mechanism and HIV-1 integrase: implications for metal binding in the active site of phosphotransferase enzymes.Proc Natl Acad Sci U S A. 2002 May 14;99(10):6661-6. doi: 10.1073/pnas.092056199. Epub 2002 May 7. Proc Natl Acad Sci U S A. 2002. PMID: 11997448 Free PMC article.
-
HIV integrase as a target for antiviral chemotherapy.Rev Med Virol. 2002 May-Jun;12(3):179-93. doi: 10.1002/rmv.350. Rev Med Virol. 2002. PMID: 11987143 Review.
-
Correlation of biological activity with active site binding modes of geminal disulfone HIV-1 integrase inhibitors.ChemMedChem. 2006 Sep;1(9):959-64. doi: 10.1002/cmdc.200600040. ChemMedChem. 2006. PMID: 16952140 Review. No abstract available.
Cited by
-
Hologram quantitative structure-activity relationship and comparative molecular field analysis studies within a series of tricyclic phthalimide HIV-1 integrase inhibitors.Drug Des Devel Ther. 2013 Sep 5;7:953-61. doi: 10.2147/DDDT.S47057. eCollection 2013. Drug Des Devel Ther. 2013. PMID: 24039405 Free PMC article.
-
The naphthyridinone GSK364735 is a novel, potent human immunodeficiency virus type 1 integrase inhibitor and antiretroviral.Antimicrob Agents Chemother. 2008 Mar;52(3):901-8. doi: 10.1128/AAC.01218-07. Epub 2007 Dec 26. Antimicrob Agents Chemother. 2008. PMID: 18160521 Free PMC article.
-
Influence of concurrent oral calcium carbonate supplementation on steady-state pharmacokinetics of once daily oral raltegravir in persons with HIV: a protocol for a prospective open-label non-randomised study in Canada.BMJ Open. 2025 Jul 5;15(7):e094384. doi: 10.1136/bmjopen-2024-094384. BMJ Open. 2025. PMID: 40617620 Free PMC article.
-
Identification of Novel 3-Hydroxy-pyran-4-One Derivatives as Potent HIV-1 Integrase Inhibitors Using in silico Structure-Based Combinatorial Library Design Approach.Front Chem. 2019 Aug 13;7:574. doi: 10.3389/fchem.2019.00574. eCollection 2019. Front Chem. 2019. PMID: 31457006 Free PMC article.
-
A divalent metal ion-dependent N(1)-methyl transfer to G37-tRNA.Chem Biol. 2014 Oct 23;21(10):1351-1360. doi: 10.1016/j.chembiol.2014.07.023. Epub 2014 Sep 11. Chem Biol. 2014. PMID: 25219964 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources